A survey is given of the principles underlying the diagnosis of brain tumours.
Brain tumours possess several characteristics, many of which have proved useful for their diagnosis ( Table 1) . As the original meaning of turnout = swelling denotes, brain tumours are primarily known by their nature as space occupying lesions. This is not surprising as they tend to present themselves clinically with the signs and symptoms of increased intracranial pressure, in view of the rigidity of the cranial box which allows no expansion. The diagnostic techniques then available, such as angiography and pneumo-encephalography or ventriculography, truely represented this space occupying character, responsible for displacements of the blood vessels, and displacement or compression of cerebrospinal fluid (CSF) spaces, although a few tumours could be directly visualised during angiography bei their possession of an abnormal vascular network.
As the current techniques of computerised tomography (CT) and magnetic resonance imaging (MRI) demonstrate, it may not only be the tumour itself that is responsible for this expansive effect, but also the peritumoural oedema (df&71.ta being the Greek rendering of Latin tumor for swelling) which usually sur- Table 1 . 18FDG-PET scan of the patient of (a) visualising a corresponding area of reduced FDG uptake (x), suggesting a low-grade glioma, which was subsequently proved by biopsy rounds the tumour to a greater or lesser extent (Figs. l a and 3 a). Peritumoural brain oedema is regarded as a type of vasogenic brain oedema, which is the consequence of blood-brain barrier impairment and exudation of blood plasma into the brain parenchyma, contrary to cytotoxic brain oedema, which is intracellularly located and occupies both grey and white matter as one may observe in recent infarctions. Vasogenic oedema has the propensity to occupy white matter, and has the appearance of areas of hypodensity on CT or hyperintensity on T2-weighted MRIscans, with fingerlike extensions in accordance with the shape of the white matter. As to the genesis of peritumoural oedema, it may be considered to bear upon the type of tumour with respect to classification into intra-axial tumours (gliomas), extra-axial tumours (meningiomas and neurinomas), and metastatic tumours. As gliomas arise from the brain tissue itself and tend to infiltrate the surrounding tissue, there is no definite border separating the tumour from the surrounding tissue and restricting the flow of oedema fluid into the surrounding tissue; in the glioma the exudate especially originates in the marginal regions in which the blood-brain barrier is disrupted as shown by contrast studies. But not all gliomas constitute a solid mass of tumour; a histological study of serial stereotaxic biopsies has demonstrated, that lowgrade gliomas may consist of isolated neoplastic cells scattered within the brain parenchyma rather than a central mass of tumour (Daumas-Duport et al. 1987 ). Extra-axial tumours arise outside the brain; from the cerebral white matter in which oedema fluid tends to accumulate, these tumours are separated by several layers being the arachnoid mater, the subarachnoid space, the pia mater, and the cerebral cortex, all of the oedema fluid also originates from the tumour, since contrast studies demonstrate that the bloodbrain barrier is not disrupted in the surrounding brain.
Underlying causes of the disruption of the bloodbrain barrier in tumours are abnormalities of the endothelium in the capillaries of the tumour (Hirano and Matsui 1975, Long 1970 ). These especially include fenestrations, and abnormalities of the junctions between the endothelial cells (Fig. 2) . Fenestrations are thin areas of the endothelial cytoplasm, through which blood-borne substances may pass into the brain parenchyma. In the normal brain fenestrated capillary endothelium is found only in the circumventricular organs such as the pineal gland, the choroid plexus, and a few other structures around the ventricles, which possess no blood-brain barrier (Fig. 4a ). In the early days, when angiography and ventriculography were used to detect brain tumours, these rather behaved like phantoms which were not directly visible, but only betrayed themselves by the displacement of surrounding blood vessels or ventricles. Brain isotope scanning (scintigraphy) was the only method capable of directly visualising a tumour by the uptake of radioactive tracer entering the tumour on account of a deficient blood-brain barrier. In the modern era of CT-and MRI-scanning, diagnosis on the basis of Table 2 . Cellular Metabolism in Tissue Proliferation blood-brain barrier impairment still constitutes a valuable principle, as enhancement of the tumour following intravenous administration of contrast agents may demarcate a tumour from surrounding oedema. Early enhancement, however, with contrast agent still contained within the blood vessels, may rather represent the extent of microvascularisation of the tumour (Daumas-Duport et al. 1987 ). The pattern of enhancement, although not pathognomonic, may point to the type of tumour: homogeneous enhancement is seen in extra-axial tumours such as meningiomas and neurinomas, heterogeneous enhancement exhibiting garland-like patterns occur with glioblastomas, in which rims of enhancement are also seen, as in some oligodendrogliomas and metastases; while fine streaks of enhancement tend to occur in astrocytomas.
Apart from enhancement, a tumour may possess density characteristics on CT or specific T1 and T2 values on MRI, which may differentiate it from normal brain without the employment of contrast agent. Thus the majority of gliomas appear hypodense on CT ( Fig. 1 a) , except meduUoblastomas and ependymomas, which tend to be slightly hyperdense; also meningiomas and lymphomas tend to be hyperdense. oligodendrogliomas, whereas meningiomas tend to be more hypo-intense to grey matter. Obviously, these features possess too little specificity to warrant a specific identification of the type of tumour in the individual case. But even CT-and MRI-scanning only depict brain tumours by their morphologic aspects, be it directly on account of their special features, be it by deficiency of the blood-brain barrier or by their familiar property of displacing surrounding structures. In fact the mere signs of a space occupying lesion are non-specific and may not be sufficient to diagnose a tumour, as infarctions, cystic lesions, inflammatory lesions (abscesses), or radionecrosis may present with the same signs of expansion. Similarly, blood-brain barrier breakdown, causing enhancement by contrast agents must be regarded as a non-specific feature (Fig. 4 a) . A reason for confusion is for example, the blood-brain barrier disruption shortly after a surgical resection, causing extensive enhancement of the wound cavity and posing as residual tumour (Fig. 5 a  and b) . Apart from these blood flow-related changes of energy metabolism, tumours in general may exhibit a prevalence of (aerobic) glycolysis for their provision of energy (Warburg 1956 ). Moreover, tumours tend to show changes of metabolism which are intimately related to their neoplastic nature, pertaining to the biosynthesis of cellular constituents such as proteins and membranes (Table 2) . Using positron-emitting tracers of physiological metabolic substrates, PET allows the study of substrate uptake. Substrates are taken up by the brain for consumption in energy metabolism, or for incorporation into cellular constituents. A study on the uptake of 18F-deoxy-D-glucose (18FDG) demonstrated elevated glucose consumption in high-grade gliomas, which is probably related to the predominance of glycolysis. The increase of 18FDG-uptake appeared to be correlated to short survival times in patients (Patronas et al. 1985) . Apart from the other instance of elevated glucose consumption, i.e., in epileptic foci during seizures, an increase of 18FDG-uptake in a lesion may therefore be considered to indicate its neoplastic nature. Elevated 18FDG-uptake (Fig. 4 b) has been employed to differentiate recurrence of tumour from radionecrosis in cases which could not be resolved by the conventional imaging techniques (Doyle et al. 1987 ). However, not all gliomas exhibit an increase of aSFDG-uptake; the low-grade gliomas in particular, may show a reduced 18FDG-uptake with respect to normal brain (Fig. 1 b) . Decrease of 18FDG-uptake, on the other hand, is a less specific finding, since infarctions, epileptic loci in the interictal period, and other lesions involving loss of tissue, all display a reduced 18FDG-uptake. Absence of 18FDG-uptake appearing as a metabolic void may point to necrosis or a cystic lesion .
The demonstration by PET of an increased uptake of amino acid tracers in the lesion with respect to normal brain, such as that of [nC-methyl]-L-methionine (nC-MET), also indicates a neoplastic nature of the lesion, in which the amino acid is presumably being accumulated in the process of increased protein biosynthesis by the proliferating tissue (Ogawa et al. 1993) . As a measure of protein biosynthesis, however, methyl-labelled methionine seems to be less appropriate, as methionine tends to be the main biochemical source of methylgroups (Ishiwata et al. 1988) . To evaluate the rate of protein biosynthesis therefore carboxylic-labelled amino acids, such as L-[1-11C] tyrosine (nC-TYR), have a greater potential, if both the metabolic profile and the quantity of metabolites are known (Paans et al. 1993) , although the radiochemical synthesis for PET is less easy to perform (Fig. 6a) . llC-TYR uptake may be used to localise cerebral gliomas for stereotaxic biopsy or resection in instances, in which the tumour is deep-seated or located at a critial site with respect to function, while absence of contrast enhancement on CT-and MR-scans makes a precise location uncertain (Go et al. 1994) .
Apart from the investigation of metabolism, PET allows the assessment of blood-brain barrier integrity by means of 68Ga-EDTA, which has been undertaken in a study on brain tumours in conjunction with 11C-MET (Bergstr6m et al. 1983 ). Using ~502 and H2150 as tracers, PET has been employed to measure oxygen consumption and blood flow, respectively, in brain tumours. Thus a reduction of oxygen consumption could be demonstrated in brain tumours after radiochemotherapy (Ogawa et al. 1988) .
A technique which uses a conventional 1.5 Tesla MR-apparatus but requires appropriate adaptations (such as special coils) and soft-ware implementation is proton magnetic resonance spectroscopy (IH-MRS), especially of proton containing metabolites that occur in adequate concentration in tissue, such as phosphocholine (CHOL), (phospho)creatine (CREAT), Nacetylaspartate (NAA), and lactate (LAC) (Go 1991 ). These metabolites appear as resonance peaks of marked height in the proton magnetic resonance spectrum (Fig. 3 b) . The substance (or a specific proton containing group it contains) is characterised by its place on the abscissa of the spectrum, which denotes the specific chemical shift of resonance frequency it exhibits on the basis of the specific molecular environment of the proton delivering the signal. Signals of adequate size may be obtained from a volume of tissue of 1 ml. Consequently unit volumes of tissue (voxels) of 1 cm 3 may be chosen to make up the total volume of brain to be studied, an in magnetic resonance spectroscopic imaging (MRSI) reconstructed into two-dimensional matrices representing the spatial distribution of a certain metabolite in the total volume studied (Fig. 3c and d ). CHOL appears to be abundant in gliomas as a constituent of membrane components to be incorporated in the growing cells of the tumour. CREAT occurs in all living cells, subserving energy metabolism as creatine phosphate, and is often used as a reference to express the relative concentrations of the other metabolites. NAA is a component of neurones, the function of which is still poorly understood. Its disappearance in tumours presumably indicates that the normal neuronal population in the lesion has been replaced by tumour cells. With respect to functionally critical areas it may be important to establish whether disappearance of the NAA signal in such an area in the lesion warrants resection of the area without risking further deterioration of function. LAC also tends to be elevated in tumours, presumably on the basis of the predominance of glycolysis, although another cause may be impaired perfusion due to elevated regional tissue pressure. On the basis of the elevation of CHOL, and decrease of NAA, MRSI appears to be useful in localising lowgrade gliomas for stereotaxic biopsy, in cases in which this was not feasible by the current imaging techniques, and which would have resulted in negative biopsies. The elevation of CHOL in gliomas tends to occur in the marginal rather than in the central parts of the tumour. In patients in whom MRSI and PET have been conducted, the pattern of CHOL elevation seemed to resemble that of HC-TYR uptake; indeed it is cellular proliferation that underlies both findings. Other instances of CHOL elevation, although with a different distribution, may be found in multiple sclerosis, in which demyelination is associated with remyelination. LAC elevation occurs with the high-grade gliomas, in particular, and tends to be located in the core of the tumour rather than in its margin, possibly suggesting necrosis. Among other structural details which can be recognised is the occurrence of associated cysts which contain high levels of LAC . LAC elevation per se is nonspecific, as it conceivably occurs in infarction. Similarly, loss of the NAA signal only denotes loss of the neuronal population, and may occur in infarctions as well. Following radiotherapy there is decrease of the elevated CHOL and LAC signals in some tumours, but no recovery of the lost NAA signal (Heesters et al. 1993) . Recurrence of tumour has been differentiated from radionecrosis on the basis of the CHOL signal (Ott et al. 1993) .
Magnetic resonance spectroscopy of tissue phosphorus compounds (31p-MRS) has demonstrated changes in brain tumours, such as a reduction of creatine phosphate suggesting involvement of energy metabolism, and decreases of phosphomono-and phosphodiesters, which presumably pertain to changes of phosphocholine metabolism related to membrane biosynthesis. Measurement of tissue pH on the basis of the pH-induced shift of the inorganic phosphate peak indicated an alkaline rather than an acid environment (Hubesch et al. 1990 ). Unfortunately, the low concentration of phosphorus compounds in tissue makes the technique rather insensitive, requiring about 100 ml of tissue to provide an adequate signal.
Apart from its behaviour as a space-occupying lesion, brain tumours may cause local impairment of function, the signs and symptoms of which conceivably depend on the location of the tumour and the specific function residing at the location. In this respect it K. G. Go et al.: Diagnosis of Brain Tumours Fig. 7 . Presentation on MRI of an active equivalent dipole source (white field at arrow point), obtained from magneto-encephalogram recorded at several locations, during selective visual attention directed to the contralateral side is interesting, that clinical analysis of brain tumours associated with peritumoural oedema has revealed that loss of neurological function rather correlated with the site of the tumour, such as paresis of the left leg with a metastasis in the leg area of the right motor cortex, than with the oedema, which on the CT-scans occupied a larger area of the cerebral hemisphere, involving the motor areas of the left arm and face as well. Moreover, in the oedematous areas the sensory evoked responses showed reaction times which were similar to those in the controlateral hemisphere (Penn 1980) .
The impairment of neurological function may be considered to result from the disturbance of neuronal function, and this may have its repercussions on electrical activity, as it becomes manifest in the electroencephalogram. Notably, the EEG changes observed with tumours are slow waves in the overlying areas. Clinical as well as experimental evidence has demonstrated that for the genesis of these polymorphic delta waves the interruption of important afferent inputs to the cerebral cortex is responsible, caused by lesions in the white matter, or in the thalamus, the hypothalamus, and the brainstem (Gloor et al. 1977) . In addition to EEG, magneto-encephalography (MEG) may record the changes of the magnetic field associated Fig. 8 ) (Go 199t) . It may also be attai.oed by means of functional F.ig. 9. Irl.h'a-opcrative ultrasotlnd depicting a subcortlca] glioma in the parietal motor area MR-imaging, by which changes of blood oxygenation ~md of blood flow th.at are induced in cortical areas by the perlbJ~nancc of motor, visual or mental tasks, may be visualised in. the MR image (Kwong et al. 1992) . Future prospccts of diagnosis in brain turnouts therefore include a combination of conventional M R imaging with MR-angiography ~d fun.ctiona] MR-imaging or PET to visualisc rclevant vascular structures and critical flmctional areas which are to be avoided during the inte,venti.on. The images may be reconstructed 3-dimensionally, which facilitates spatial insight, and is cm~ceivably important in topographically complex regions (viz. the pineal and suprasellar regions). Visualisation of the brain surface with its cortical topogiaphy (Katada 1990 ), allowing the superposition of functional and metabolic data, obtained by PET or MRS (Kapouleas et al. 1991 ) may be significant in the lecog~itJon of functio~mlly critic~l cortical areas. Moreover, the equivalent dipole source obtained by EEG or MEG data may also bc superimposed on a three-dimensional rcconstructio~ of the brain.
l.n the intra-operative situation, as early as 1923 Grant has applied the measurement of electrical tissue impedance to detect a turnout. It is based upon the decrease of the resistance o1' the tissue to low-frequency altemati.ve electric current, caused by the presence of cxlracellular oedema around the tumour (Go et al. 1973 ). Another technique which has been applied to visualise tumours during operation constituted the intravenous injection of fluorescein dye, which crosses the disrupted blood-brain barrier and stains the tumour (Moore 1950) . A recent valuable contribution to the localisation of deeply seated tumours during operation is the use of ultrasound (Fig. 9) , which can visualise surrounding oedema and associated cysts; the echogenicity of the lesion is determined by the presence of interfaces between tissue structures with different acoustic densities, which therefore can reflect ultrasound (Chandler and Knake 1984) .
